When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

PHASE4CompletedINTERVENTIONAL
Enrollment

283

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

September 30, 2006

Study Completion Date

August 31, 2007

Conditions
HIV InfectionsAIDS-Related Opportunistic Infections
Interventions
DRUG

Emtricitabine/tenofovir disoproxil fumarate

DRUG

Lopinavir/ritonavir

DRUG

Stavudine

Trial Locations (45)

10003

Beth Israel Medical Center, New York

10021

Columbia University, New York

19104

Presbyterian Medical Center - University of PA, Philadelphia

University of Pennsylvania, Philadelphia, Philadelphia

21201

University of Maryland, Institute of Human Virology, Baltimore

27514

University of North Carolina, Chapel Hill

27710

Duke University Medical Center, Durham

30308

Emory University, Atlanta

37203

Comprehensive Care Clinic, Nashville

43210

Ohio State University, Columbus

46202

Wishard Hospital, Indianapolis

60612

Cook County Hospital Core Center, Chicago

92103

University of California, San Diego Antiviral Rese, San Diego

94110

San Francisco General Hospital, San Francisco

95814

University of California, Davis Medical Center, Sacramento

98104

University of Washington (Seattle), Seattle

94305-5107

San Mateo County AIDS Program, Stanford

Santa Clara Valley Medical Center, Stanford

Stanford Univ, Stanford

Willow Clinic, Stanford

90502-2052

Harbor General/UCLA, Torrance

80262-3706

University of Colorado Health Sciences Center, Denver, Denver

33136-1013

Univ of Miami, Miami

60611-3015

Northwestern University, Chicago

46202-1261

Methodist Hospital of Indiana, Indianapolis

46202-5250

Indiana University Hosp, Indianapolis

21287-8106

Johns Hopkins University, Baltimore

02114

Harvard (Massachusetts General Hospital), Boston

02215

Beth Israel Deaconess - West Campus, Boston

Brigham and Womens Hospital, Boston

55455-0392

Hennepin County Medical Clinic, Minneapolis

63108-2138

St. Louis Connect Care, St Louis

Washington University (St. Louis), St Louis

10016-6481

NYU/Bellevue, New York

14642-0001

Community Health Network, Inc., Rochester

University of Rochester Medical Center, Rochester

45267-0405

University of Cincinnati, Cincinnati

44106-5083

Case Western Reserve University, Cleveland

44109-1998

MetroHealth Medical Center, Cleveland

02906

Rhode Island Hospital, Providence

The Miriam Hospital, Providence

75235-9173

University of Texas, Southwestern Medical Center, Dallas

77555-0435

Univ of Texas, Galveston, Galveston

00936-5067

University of Puerto Rico, San Juan

Unknown

University of Witwatersrand, Parktown

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00055120 - When to Start Anti-HIV Drugs in Patients With Opportunistic Infections | Biotech Hunter | Biotech Hunter